Neurotoxin Global Market Opportunities And Strategies To 2034

Description

Neurotoxins refer to a class of biological or synthetic substances that adversely affect the structure or function of the nervous system by disrupting neural transmission, damaging nerve cells, or altering neurotransmitter activity.

The neurotoxin market consists of sales, by entities (organizations, sole traders or partnerships), of neurotoxin naturally derived, such as botulinum toxin from clostridium botulinum, or synthetically engineered for therapeutic applications. While certain neurotoxins pose environmental and biological hazards, others are used in controlled doses for medical and cosmetic purposes. In healthcare, purified neurotoxins are primarily used to treat a range of neuromuscular and neurological disorders, including chronic migraine, cervical dystonia, spasticity and hyperhidrosis, as well as for aesthetic treatments to reduce facial wrinkles.

The global neurotoxin market was valued at $5,290.89 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Prevalence Of Neurological Disorders

The rising prevalence of neurological disorders drove the growth of the neurotoxin market during historic period. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, leading to a range of physical, cognitive, or behavioral impairments. Neurological disorders are increasing globally due to aging populations, rising chronic diseases like diabetes, environmental factors such as pollution and the long-term effects of infections like COVID-19. Neurotoxin treatments help neurological disorders by selectively targeting and blocking abnormal nerve activity, providing therapeutic relief for conditions such as chronic migraines, spasticity and certain movement disorders, thereby improving muscle control and reducing symptoms. For instance, in July 2024, according to the American Brain Foundation, a US-based non-profit organization, in 2021, neurological disorders accounted for 11.1 million fatalities and impacted 3.4 billion people, or 43.1% of the world's population. Moreover, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally. Therefore, the rising prevalence of neurological disorders is driving the growth of the neurotoxin market.

Focus On Launch Of New Products

Major companies operating in the neurotoxin market are focusing on launching new products to strengthen their market presence. Product launch is the introduction of a new product or service into the marketplace, accompanied by a series of strategic marketing, distribution, and sales activities aimed at generating awareness, interest, and initial adoption. For example, in September 2024, Allergan Aesthetics, an AbbVie company, launched BOTOX Cosmetic (onabotulinumtoxinA) in China for the treatment of masseter muscle prominence (MMP) in adults. This approval by the China National Medical Product Administration (NMPA) makes BOTOX(R) Cosmetic the first neurotoxin approved in China for this indication. MMP is characterized by an enlarged masseter muscle, leading to a wider, square-shaped lower face, which can be an aesthetic concern for some individuals. The condition may result from genetic factors or activities such as excessive chewing or teeth grinding. Clinical trials demonstrated that treatment with BOTOX(R) Cosmetic resulted in an average reduction of facial width by 5.2mm compared to placebo, with effects typically lasting between six to nine months.

The global neurotoxin markets are highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 68.52% of the total market in 2024.

Neurotoxin Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurotoxin market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurotoxin? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurotoxin market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by application and by end user.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the unmanned underwater vehicles market.
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for neurotoxin market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Product Type: Botox; Dysport; Xeomin; Other products
2) By Application: Therapeutic; Aesthetic; Other Applications
3) By End-User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
Companies Mentioned: Abbvie Inc.; Merz Pharma GmbH & Co. KGaA; Ipsen Pharma SA; Evolus Inc.; Revance Therapeutics Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurotoxin indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1673

1 Executive Summary

1.1 Neurotoxin - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Neurotoxin Market Definition And Segmentations
6.4 Market Segmentation By Product Type
- 6.4.1 Botox
- 6.4.2 Dysport
- 6.4.3 Xeomin
- 6.4.4 Other Products
6.5 Market Segmentation By Application
- 6.5.1 Therapeutic
- 6.5.2 Aesthetic
- 6.5.3 Other Applications
6.6 Market Segmentation By End User
- 6.6.1 Hospitals
- 6.6.2 Specialty Clinics
- 6.6.3 Dermatology Clinics
- 6.6.4 Other End Users

7 Major Market Trends

7.1 Regulatory Approvals For Expansion Of Therapeutic And Aesthetic Applications
7.2 Focus On Launch Of New Products
7.3 Innovating Efficacy And Expanding Applications
7.4 Strategic Partnerships And Collaborations Among Market Players
7.5 Innovative Neurotoxin Developments

8 Global Neurotoxin Growth Analysis And Strategic Analysis Framework

8.1 Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End User Industries (B2B)
- 8.2.1 Hospitals
- 8.2.2 Specialty Clinics
- 8.2.3 Dermatology Clinics
- 8.2.4 Other End Users
8.3 Global Neurotoxin Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Neurotoxin Total Addressable Market (TAM)

9 Global Neurotoxin Market Segmentation

9.1 Global Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Neurotoxin Market, Sub-Segmentation By Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Neurotoxin Market, Regional and Country Analysis

10.1 Global Neurotoxin Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Neurotoxin Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Neurotoxin Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investments
- 11.19.11 Major Companies
11.20 Japan Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
- 11.25.1 Country Information
- 11.25.2 Market Information
- 11.25.3 Background Information
- 11.25.4 Government Initiatives
- 11.25.5 Regulations
- 11.25.6 Regulatory Bodies
- 11.25.7 Major Associations
- 11.25.8 Taxes Levied
- 11.25.9 Corporate Tax Structure
- 11.25.10 Investments
- 11.25.11 Major Companies
11.26 South Korea Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Neurotoxin Market: Country Analysis
12.7 UK Market
12.8 UK Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major Companies
13.3 Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Neurotoxin Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Investments
- 14.15.11 Major Companies
14.16 Canada Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulation
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 Africa Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Abbvie Inc.
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Merz Pharma GmbH & Co. KGaA
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Financial Overview
18.4 Ipsen Pharma SA
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Evolus Inc.
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Revance Therapeutics Inc.
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 Daewoong Pharmaceutical Co. Ltd.
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 Galderma S.A.
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Sinclair Pharma plc
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 Croma-Pharma GmbH
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Supernus Pharmaceuticals Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Alphaeon Corporation
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Hugel Inc.
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 Entod Pharmaceuticals Ltd.
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 Aquavit Pharmaceuticals Inc.
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 Object Pharma Inc.
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 Biotium Inc.
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 Vida Aesthetics Ltd.
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Medytox Inc.
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Gufic Biosciences Ltd.
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 AEON Biopharma
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Crown Laboratories Acquired Revance Therapeutics
22.2 Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

23 Recent Developments In The Neurotoxin Market

23.1 Daewoong Pharmaceutical Introduces NABOTA To Saudi Arabia's Expanding Aesthetic Market
23.2 Oxapharma Launches Clodew As A Breakthrough Toxin For Targeted Therapeutic Treatments
23.3 Godrej Consumer Products Launches Formaldehyde-Free Botosmooth Hair Botox Treatment in Maharashtra

24 Opportunities And Strategies

24.1 Global Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Neurotoxin Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Neurotoxin Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer